September 14, 2025 - 04:33

Ruben Mesa is at the forefront of a transformative era in cancer research and treatment, spearheading initiatives within a dynamic cancer biology department. This department is dedicated to advancing the understanding and treatment of cancer, playing a pivotal role in enhancing patient care across Advocate Health.
Under Mesa's leadership, the team is focused on innovative research that aims to uncover new insights into cancer biology, ultimately leading to more effective therapies. The department is committed to fostering collaboration among researchers, clinicians, and patients, ensuring that breakthroughs in the lab translate into real-world applications.
This collaborative approach not only enhances the quality of research but also accelerates the development of novel treatment options for patients battling cancer. As a result, the department is making significant strides in improving outcomes and quality of life for those affected by this disease. Mesa's vision and dedication continue to inspire advancements that could change the landscape of cancer care.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....